Epilepsy, Partial Clinical Trial
Official title:
An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy
observational, non-interventional study in 120 patients with drug-resistant partial epilepsy, comprising two phases: a 3-month retrospective and a 6-month prospective. As control group, 120 patients with controlled partial epilepsy will be enrolled. The objective of the study is to describe the burden of illness in this epileptic population both in terms of costs and of quality of life. Costs and quality of life will be also compared between the two populations.
observational, non-interventional study in 120 patients with drug-resistant partial epilepsy, comprising two phases: a 3-month retrospective and a 6-month prospective. ;
Observational Model: Cohort
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00105040 -
A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures
|
Phase 2 | |
| Completed |
NCT00160615 -
Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
|
Phase 3 | |
| Completed |
NCT00152516 -
Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures
|
Phase 3 | |
| Completed |
NCT00175890 -
A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.
|
Phase 3 | |
| Completed |
NCT00113165 -
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
|
Phase 3 | |
| Withdrawn |
NCT01691872 -
Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects
|
Phase 1 | |
| Completed |
NCT00160654 -
Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
|
Phase 4 | |
| Terminated |
NCT01545518 -
IVIG Treatment for Refractory Immune-Related Adult Epilepsy
|
Phase 2 | |
| Completed |
NCT00141414 -
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
|
Phase 2 | |
| Completed |
NCT00355082 -
Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
|
Phase 3 | |
| Completed |
NCT00152451 -
Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures
|
Phase 2 | |
| Withdrawn |
NCT02220972 -
To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
|
Phase 4 | |
| Completed |
NCT00160628 -
Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy
|
Phase 3 | |
| Completed |
NCT00245713 -
Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
|
Phase 4 | |
| Terminated |
NCT01375374 -
Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide
|
Phase 3 | |
| Completed |
NCT00152373 -
Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS
|
Phase 3 | |
| Completed |
NCT00150709 -
A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy
|
Phase 3 | |
| Completed |
NCT00643500 -
Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy
|
Phase 4 | |
| Completed |
NCT00152503 -
Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
|
Phase 2 | |
| Terminated |
NCT01891890 -
Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)
|
Phase 3 |